Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL

Rojkjaer Lisa had 850 Rigel Pharmaceuticals, Inc. shares withheld for tax (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Rojkjaer Lisa (EVP, Chief Medical Officer) had 850 Rigel Pharmaceuticals, Inc. shares withheld for tax at US$29.86 for US$25,381, leaving 34,003 shares. Filed Jun 3, 2026 (Form 4).

Withheld for tax
850 shares
Price
US$29.86
Value
US$25,381
Holding after
34,003 shares
Trading plan
No
Role
EVP, Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockShares withheld for tax850US$29.8634,003Direct

Source

View original at SEC

Related